STEPHENSON BRIAN C
Insider CIK 1780030 · BBIO See Remarks · FTH Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FTH Faeth Therapeutics, Inc. | P Buy | 2026-07-01 | 2026-07-01 | 4,400 | $23.40 | $103.0K | 46,088 | SEC↗ |
| FTH Faeth Therapeutics, Inc. | P Buy | 2026-07-01 | 2026-07-01 | 600 | $24.22 | $14.5K | 46,688 | SEC↗ |
| FTH Faeth Therapeutics, Inc. | P Buy | 2026-06-30 | 2026-07-01 | 4,255 | $24.98 | $106.3K | 41,688 | SEC↗ |
| FTH Faeth Therapeutics, Inc. | P Buy | 2026-06-30 | 2026-07-01 | 1,910 | $22.95 | $43.8K | 35,795 | SEC↗ |
| FTH Faeth Therapeutics, Inc. | P Buy | 2026-06-30 | 2026-07-01 | 1,638 | $23.88 | $39.1K | 37,433 | SEC↗ |
| FTH Faeth Therapeutics, Inc. | P Buy | 2026-06-29 | 2026-07-01 | 831 | $23.34 | $19.4K | 33,885 | SEC↗ |
| FTH Faeth Therapeutics, Inc. | P Buy | 2026-06-26 | 2026-06-26 | 580 | $23.61 | $13.7K | 27,384 | SEC↗ |
| FTH Faeth Therapeutics, Inc. | P Buy | 2026-06-26 | 2026-06-26 | 4,212 | $24.90 | $104.9K | 31,596 | SEC↗ |
| FTH Faeth Therapeutics, Inc. | P Buy | 2026-06-26 | 2026-06-26 | 1,358 | $25.55 | $34.7K | 32,954 | SEC↗ |
| FTH Faeth Therapeutics, Inc. | P Buy | 2026-06-26 | 2026-06-26 | 100 | $26.39 | $2.6K | 33,054 | SEC↗ |
| FTH Faeth Therapeutics, Inc. | P Buy | 2026-06-24 | 2026-06-26 | 2,891 | $25.22 | $72.9K | 20,304 | SEC↗ |
| FTH Faeth Therapeutics, Inc. | P Buy | 2026-06-24 | 2026-06-26 | 3,000 | $25.98 | $77.9K | 23,304 | SEC↗ |
| FTH Faeth Therapeutics, Inc. | P Buy | 2026-06-24 | 2026-06-26 | 3,400 | $26.98 | $91.7K | 26,704 | SEC↗ |
| FTH Faeth Therapeutics, Inc. | P Buy | 2026-06-24 | 2026-06-26 | 100 | $27.77 | $2.8K | 26,804 | SEC↗ |
| FTH Faeth Therapeutics, Inc. | P Buy | 2026-06-23 | 2026-06-24 | 425 | $25.91 | $11.0K | 17,413 | SEC↗ |
| FTH Faeth Therapeutics, Inc. | P Buy | 2026-06-23 | 2026-06-24 | 1,969 | $24.84 | $48.9K | 16,988 | SEC↗ |
| FTH Faeth Therapeutics, Inc. | P Buy | 2026-06-23 | 2026-06-24 | 6,836 | $24.12 | $164.9K | 15,019 | SEC↗ |
| FTH Faeth Therapeutics, Inc. | P Buy | 2026-06-22 | 2026-06-24 | 1,797 | $20.23 | $36.4K | 1,797 | SEC↗ |
| FTH Faeth Therapeutics, Inc. | P Buy | 2026-06-22 | 2026-06-24 | 356 | $23.95 | $8.5K | 8,183 | SEC↗ |
| FTH Faeth Therapeutics, Inc. | P Buy | 2026-06-22 | 2026-06-24 | 3,329 | $23.28 | $77.5K | 7,827 | SEC↗ |
| FTH Faeth Therapeutics, Inc. | P Buy | 2026-06-22 | 2026-06-24 | 1,583 | $22.40 | $35.5K | 4,498 | SEC↗ |
| FTH Faeth Therapeutics, Inc. | P Buy | 2026-06-22 | 2026-06-24 | 1,118 | $20.82 | $23.3K | 2,915 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2025-02-25 | 2025-02-27 | 8,500 | — | $0 | 440,170 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2025-02-25 | 2025-02-27 | 8,500 | $17.00 | $144.5K | 110,964 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-02-25 | 2025-02-27 | 100 | $34.18 | $3.4K | 102,464 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-02-25 | 2025-02-27 | 8,400 | $33.18 | $278.7K | 102,564 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-02-19 | 2025-02-19 | 4,148 | $36.16 | $150.0K | 102,464 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2025-02-16 | 2025-02-19 | 946 | — | $0 | 2,840 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2025-02-16 | 2025-02-19 | 17,368 | — | $0 | 138,947 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2025-02-16 | 2025-02-19 | 6,705 | — | $0 | 80,459 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2025-02-16 | 2025-02-19 | 779 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2025-02-16 | 2025-02-19 | 25,798 | — | $0 | 119,714 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2025-02-16 | 2025-02-19 | 13,102 | $34.90 | $457.3K | 106,612 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2025-01-28 | 2025-01-30 | 68,000 | — | $0 | 448,670 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2025-01-28 | 2025-01-30 | 68,000 | $17.00 | $1.16M | 161,758 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-01-28 | 2025-01-30 | 68,000 | $36.29 | $2.47M | 93,758 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2024-12-10 | 2024-12-12 | 42,683 | — | $0 | 42,683 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2024-11-19 | 2024-11-20 | 4,156 | $22.41 | $93.1K | 93,758 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-11-16 | 2024-11-19 | 947 | — | $0 | 3,786 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-11-16 | 2024-11-19 | 6,705 | — | $0 | 87,164 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-11-16 | 2024-11-19 | 17,369 | — | $0 | 156,315 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-11-16 | 2024-11-19 | 778 | — | $0 | 779 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2024-11-16 | 2024-11-19 | 25,799 | — | $0 | 110,991 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2024-11-16 | 2024-11-19 | 13,077 | $23.72 | $310.2K | 97,914 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2024-08-19 | 2024-08-20 | 2,457 | $24.39 | $59.9K | 86,890 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2024-08-19 | 2024-08-20 | 1,698 | $25.13 | $42.7K | 85,192 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-08-16 | 2024-08-20 | 6,705 | — | $0 | 93,869 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-08-16 | 2024-08-20 | 946 | — | $0 | 4,733 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-08-16 | 2024-08-20 | 17,368 | — | $0 | 173,684 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-08-16 | 2024-08-20 | 778 | — | $0 | 1,557 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2024-08-16 | 2024-08-20 | 25,797 | — | $0 | 102,424 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2024-08-16 | 2024-08-20 | 13,077 | $24.40 | $319.1K | 89,347 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-05-16 | 2024-05-17 | 17,368 | — | $0 | 191,052 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-05-16 | 2024-05-17 | 1,710 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-05-16 | 2024-05-17 | 778 | — | $0 | 2,335 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-05-16 | 2024-05-17 | 6,704 | — | $0 | 100,574 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-05-16 | 2024-05-17 | 947 | — | $0 | 5,679 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2024-05-16 | 2024-05-17 | 27,507 | — | $0 | 90,415 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2024-05-16 | 2024-05-17 | 13,943 | $31.04 | $432.8K | 76,472 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2024-03-12 | 2024-03-14 | 15,442 | — | $0 | 15,442 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2024-03-12 | 2024-03-14 | 107,278 | — | $0 | 107,278 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-02-16 | 2024-02-21 | 24,193 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-02-16 | 2024-02-21 | 946 | — | $0 | 6,626 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-02-16 | 2024-02-21 | 17,369 | — | $0 | 208,420 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-02-16 | 2024-02-21 | 778 | — | $0 | 3,113 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-02-16 | 2024-02-21 | 1,710 | — | $0 | 1,710 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2024-02-16 | 2024-02-21 | 18,919 | $37.21 | $704.0K | 62,908 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2024-02-16 | 2024-02-21 | 44,996 | — | $0 | 81,827 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-11-17 | 2023-11-20 | 22,685 | $29.10 | $660.1K | 36,710 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-11-16 | 2023-11-20 | 778 | — | $0 | 3,891 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-11-16 | 2023-11-20 | 1,710 | — | $0 | 3,420 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-11-16 | 2023-11-20 | 24,193 | — | $0 | 24,193 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-11-16 | 2023-11-20 | 947 | — | $0 | 7,572 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-11-16 | 2023-11-20 | 17,368 | — | $0 | 225,789 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2023-11-16 | 2023-11-20 | 22,311 | $28.86 | $643.9K | 59,395 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2023-11-16 | 2023-11-20 | 44,996 | — | $0 | 81,706 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-08-17 | 2023-08-18 | 22,683 | $28.59 | $648.5K | 36,710 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-08-16 | 2023-08-18 | 17,368 | — | $0 | 243,157 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-08-16 | 2023-08-18 | 1,709 | — | $0 | 5,130 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-08-16 | 2023-08-18 | 946 | — | $0 | 8,519 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-08-16 | 2023-08-18 | 24,193 | — | $0 | 48,386 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-08-16 | 2023-08-18 | 778 | — | $0 | 4,669 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2023-08-16 | 2023-08-18 | 44,994 | — | $0 | 81,704 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2023-08-16 | 2023-08-18 | 22,311 | $29.80 | $664.9K | 59,393 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-05-17 | 2023-05-18 | 24,424 | $14.01 | $342.2K | 36,408 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-05-16 | 2023-05-18 | 1,710 | — | $0 | 6,839 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-05-16 | 2023-05-18 | 17,368 | — | $0 | 260,525 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-05-16 | 2023-05-18 | 24,193 | — | $0 | 72,579 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-05-16 | 2023-05-18 | 778 | — | $0 | 5,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-05-16 | 2023-05-18 | 947 | — | $0 | 9,465 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2023-05-16 | 2023-05-18 | 20,572 | $14.09 | $289.9K | 60,832 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2023-05-16 | 2023-05-18 | 44,996 | — | $0 | 81,404 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-05-03 | 2023-05-05 | 64,929 | $14.18 | $920.7K | 36,408 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-04-05 | 2023-04-07 | 55,500 | $15.45 | $857.5K | 101,337 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-03-03 | 2023-03-03 | 62,692 | $10.96 | $687.1K | 156,837 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-02-17 | 2023-02-21 | 15,567 | $12.65 | $196.9K | 221,679 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-02-17 | 2023-02-21 | 2,150 | $13.06 | $28.1K | 219,529 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-02-16 | 2023-02-21 | 946 | — | $0 | 10,412 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-02-16 | 2023-02-21 | 24,193 | — | $0 | 96,772 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-02-16 | 2023-02-21 | 778 | — | $0 | 6,225 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-02-16 | 2023-02-21 | 1,710 | — | $0 | 8,549 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2023-02-16 | 2023-02-21 | 9,910 | $12.64 | $125.3K | 237,246 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2023-02-16 | 2023-02-21 | 27,627 | — | $0 | 247,156 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2023-02-10 | 2023-02-14 | 323,431 | — | $0 | 323,431 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2023-02-10 | 2023-02-14 | 277,893 | — | $0 | 277,893 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-02-03 | 2023-02-06 | 61,040 | $11.01 | $672.1K | 219,184 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-01-05 | 2023-01-06 | 61,040 | $7.67 | $468.2K | 280,224 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2022-11-17 | 2022-11-18 | 19,678 | $9.40 | $185.0K | 341,264 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2022-11-16 | 2022-11-18 | 1,710 | — | $0 | 10,259 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2022-11-16 | 2022-11-18 | 778 | — | $0 | 7,003 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2022-11-16 | 2022-11-18 | 24,193 | — | $0 | 120,965 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2022-11-16 | 2022-11-18 | 3,786 | — | $0 | 11,358 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2022-11-16 | 2022-11-18 | 10,789 | $9.64 | $104.0K | 360,942 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2022-11-16 | 2022-11-18 | 30,467 | — | $0 | 371,731 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2022-08-16 | 2022-08-18 | 1,709 | — | $0 | 11,969 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2022-08-16 | 2022-08-18 | 24,193 | — | $0 | 145,158 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2022-08-16 | 2022-08-18 | 778 | — | $0 | 7,781 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2022-08-16 | 2022-08-18 | 9,227 | $11.08 | $102.2K | 341,260 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2022-08-16 | 2022-08-18 | 26,680 | — | $0 | 350,487 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2022-05-16 | 2022-05-18 | 778 | — | $0 | 8,559 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2022-05-16 | 2022-05-18 | 24,192 | — | $0 | 169,351 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2022-05-16 | 2022-05-18 | 1,710 | — | $0 | 13,678 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2022-05-16 | 2022-05-18 | 26,680 | — | $0 | 333,035 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2022-05-16 | 2022-05-18 | 9,228 | $6.74 | $62.2K | 323,807 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2022-03-16 | 2022-03-18 | 193,543 | — | $0 | 193,543 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2022-02-16 | 2022-02-18 | 1,710 | — | $0 | 15,388 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2022-02-16 | 2022-02-18 | 778 | — | $0 | 9,337 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2022-02-16 | 2022-02-18 | 1,020 | $8.84 | $9.0K | 306,355 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2022-02-16 | 2022-02-18 | 2,488 | — | $0 | 307,375 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2021-12-03 | 2021-12-07 | 211,366 | — | $0 | 211,366 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2021-12-03 | 2021-12-07 | 15,144 | — | $0 | 15,144 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2021-11-16 | 2021-11-18 | 778 | — | $0 | 10,115 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2021-11-16 | 2021-11-18 | 1,710 | — | $0 | 17,098 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2021-11-16 | 2021-11-18 | 1,234 | $47.25 | $58.3K | 304,382 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2021-11-16 | 2021-11-18 | 2,488 | — | $0 | 305,616 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2021-08-16 | 2021-08-18 | 778 | — | $0 | 10,893 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2021-08-16 | 2021-08-18 | 1,709 | — | $0 | 18,808 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2021-08-16 | 2021-08-18 | 1,028 | $49.48 | $50.9K | 303,128 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2021-08-16 | 2021-08-18 | 2,487 | — | $0 | 304,156 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2021-05-16 | 2021-05-18 | 778 | — | $0 | 11,671 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2021-05-16 | 2021-05-18 | 1,710 | — | $0 | 20,517 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2021-05-16 | 2021-05-18 | 862 | $53.66 | $46.3K | 301,669 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2021-05-16 | 2021-05-18 | 2,488 | — | $0 | 302,531 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | P Buy | 2021-02-17 | 2021-02-18 | 8,000 | $62.50 | $500.0K | 300,043 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2021-02-16 | 2021-02-18 | 1,710 | — | $0 | 22,227 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2021-02-16 | 2021-02-18 | 1,710 | — | $0 | 292,635 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2021-02-16 | 2021-02-18 | 592 | $64.98 | $38.5K | 292,043 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2021-02-10 | 2021-02-12 | 73,440 | — | $0 | 73,440 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2021-02-10 | 2021-02-12 | 12,449 | — | $0 | 12,449 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2020-11-16 | 2020-11-18 | 1,710 | — | $0 | 23,937 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2020-11-16 | 2020-11-18 | 1,710 | — | $0 | 290,677 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2020-11-16 | 2020-11-18 | 592 | $44.33 | $26.2K | 290,085 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2020-08-16 | 2020-08-18 | 1,709 | — | $0 | 25,647 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2020-08-16 | 2020-08-18 | 591 | $28.53 | $16.9K | 288,967 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2020-08-16 | 2020-08-18 | 1,709 | — | $0 | 289,558 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-08-04 | 2020-08-05 | 2,136 | $27.20 | $58.1K | 287,519 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-08-04 | 2020-08-05 | 403 | $27.54 | $11.1K | 287,116 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-08-03 | 2020-08-05 | 200 | $28.30 | $5.7K | 289,655 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-08-03 | 2020-08-05 | 4,461 | $27.22 | $121.4K | 289,855 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-07-01 | 2020-07-06 | 7,900 | $30.64 | $242.1K | 297,216 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-07-01 | 2020-07-06 | 2,800 | $31.68 | $88.7K | 294,416 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-07-01 | 2020-07-06 | 100 | $32.49 | $3.2K | 294,316 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-06-08 | 2020-06-10 | 2,000 | $30.00 | $60.0K | 305,116 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-06-03 | 2020-06-05 | 27,356 | — | $0 | 27,356 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-06-03 | 2020-06-05 | 196,850 | — | $0 | 196,850 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-06-03 | 2020-06-05 | 1,600 | $30.04 | $48.1K | 307,116 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-06-01 | 2020-06-03 | 900 | $29.74 | $26.8K | 308,716 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-06-01 | 2020-06-03 | 6,300 | $29.31 | $184.7K | 309,616 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-05-05 | 2020-05-06 | 5,706 | $30.49 | $174.0K | 315,916 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-05-04 | 2020-05-05 | 1,494 | $30.00 | $44.8K | 321,622 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-05-01 | 2020-05-05 | 1,200 | $29.83 | $35.8K | 323,116 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-05-01 | 2020-05-05 | 6,000 | $29.11 | $174.7K | 324,316 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-04-01 | 2020-04-03 | 2,500 | $26.86 | $67.2K | 331,602 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-04-01 | 2020-04-03 | 3,414 | $26.01 | $88.8K | 334,102 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-04-01 | 2020-04-03 | 1,286 | $27.74 | $35.7K | 330,316 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-03-02 | 2020-03-04 | 290 | $33.31 | $9.7K | 337,516 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-03-02 | 2020-03-04 | 5,550 | $32.65 | $181.2K | 337,806 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-03-02 | 2020-03-04 | 4,960 | $31.79 | $157.7K | 343,356 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-02-04 | 2020-02-05 | 4,973 | $34.52 | $171.7K | 348,316 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-02-03 | 2020-02-05 | 5,827 | $34.90 | $203.4K | 353,289 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-01-03 | 2020-01-06 | 100 | $31.94 | $3.2K | 362,652 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-01-03 | 2020-01-06 | 3,536 | $32.31 | $114.2K | 359,116 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-01-02 | 2020-01-06 | 2,295 | $32.57 | $74.7K | 367,621 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-01-02 | 2020-01-06 | 4,217 | $33.47 | $141.1K | 363,404 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-01-02 | 2020-01-06 | 30 | $35.17 | $1.1K | 362,752 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-01-02 | 2020-01-06 | 622 | $34.23 | $21.3K | 362,782 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2019-07-01 | 2019-07-03 | 18,240 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2019-07-01 | 2019-07-03 | 294,706 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2019-07-01 | 2019-07-03 | 294,706 | — | $0 | 294,706 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2019-07-01 | 2019-07-03 | 18,240 | — | $0 | 312,946 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | P Buy | 2019-07-01 | 2019-07-03 | 55,500 | $17.00 | $943.5K | 368,446 | SEC↗ |